DR
Dermata Therapeutics, Inc.
DRMAW · NASDAQ
$0.00 -97.38% (-$0.02)
1M -50.00%
Market Cap $408.0
P/E Ratio -
Div. Yield -
ROE 166.67%
Bulios Fair Price
$0
100.0% downside
Trenutna cena
$0.0006
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DRMAW trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/B 0.00x
P/E N/A
EV/EBITDA N/A
Growth
31 /100
Declining Book val. growth 1.10%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 246.61%
ROE 166.67%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 2.81x
Int. coverage N/A
Stability
37 /100
Moderate Beta 0.66x
EPS volatility 157.17%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DRMAW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gerald T. Proehl
Employees
9
Headquarters
San Diego
Prihajajoči dogodki
18 NOV.
Earnings
Upcoming earnings report